Novo Nordisk scientists have synthesised an insulin molecule that specifically targets glucose in blood, instead of other sugars like fructose, to aid treatment of all types of diabetes.
People with diabetes take insulin to lower high blood sugar. However, if glucose levels plunge too low-from taking too much insulin or not eating enough sugar-people can experience hypoglycemia, which ...